On September 3, 2024 Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, reported that Steven Kelly, President and Chief Executive Officer, will participate in the following upcoming conferences (Press release, Carisma Therapeutics, SEP 3, 2024, View Source [SID1234646326]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2024 Global Healthcare Conference

Tuesday, September 10 at 12:50 PM ET
New York, NY

H.C. Wainwright 26th Annual Global Investment Conference

Wednesday, September 11 at 1:30 PM ET
New York, NY

Chardan’s 8th Annual Genetic Medicines Conference

Monday, September 30 at 4:00 PM ET
New York, NY

The Cell & Gene Meeting on the Mesa

Monday, October 7 at 9:30 AM MST
Phoenix, AZ
Live webcasts will be available on the Company’s Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following the event.